原发口腔外周T细胞淋巴瘤非特指型的特点分析
黄润语, 张春叶, 张颖, 赵峥岩, 杨扬, 吴岚

Features of oral peripheral T-cell lymphoma, not otherwise specified
HUANG Runyu, ZHANG Chunye, ZHANG Ying, ZHAO Zhengyan, YANG Yang, WU Lan
表3 口腔PTCL-NOS患者的免疫组织化学特征
Tab 3 Immunohistochemical findings of oral PTCL-NOS
Year

Patient/

reference

EBERCD3CD4CD8CD2CD7CD20Ki-67Others
2023Case 1‒+++++‒60%‒70%

TIA-1 (partial+), GB (partial+),

perforin (few cells+)

2024Case 2/+//++‒>90%TIA-1(+), GB(+), perforin(+)
20141/[2]‒+++//‒80%TIA-1(+), GB(+)
20162/[3]/+++Few cells+Few cells+‒30%‒40%/
20173/[4]‒+‒+//‒30%TIA-1(+)
20184/[5]‒++‒+/‒60%/
20205/[6]‒++‒//‒60%TIA-1(‒), GB(‒)
20206/[7]‒++‒//‒60%‒95%LCA(+)
20207/[7]‒+////‒20%LCA(+), GB(‒), CD30(‒)
20208/[7]‒++///‒60%‒95%
20209/[7]/+////‒60%‒95%GB(+)
202010/[7]///////60%‒95%CD30(+)
202011/[7]/+++‒/‒60%‒95%TIA-1(+), GB(+), perforin(+)
202012/[7]/+++++‒60%‒95%

TIA-1(+), GB(+), perforin(+),

CD30(‒), PD-1(+)

202313/[8]/+///+‒70%‒80%CD30(‒)
202414/[9]/+/////70%Perforin(‒), GB(‒)
202415/[9]/+/////80%GB(‒)
202416/[9]/+‒+///95%Perforin(‒), GB(+), CD30(‒)
202417/[9]/++‒///95%GB(+), CD30(‒)
202418/[9]/++‒///90%GB(+), CD30(+)